VAV1 and lung carcinoma: Several of the mutations identified in lung cancer as well as hematological malignancies lead to increased VAV1 GEF activity, such as Y174C, E175K, E175V/L, L177R, K404R, Q498K/R, M501R/L/N, E556D/K, and P615L [108].